NFKB1 and cancer: Natural components are multi-targeting agents and have been described to improve conventional chemotherapy by targeting inflammatory responses in cancers, suppressing NF-κB activation, stimulating apoptosis and targeting CSCs, thereby overcoming monotherapy-associated failures and drug resistance [29,30].